GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Holdings Corp (XKRX:001630) » Definitions » YoY EBITDA Growth

Chong Kun Dang Holdings (XKRX:001630) YoY EBITDA Growth : 1.58% (As of Mar. 2024)


View and export this data going back to 1976. Start your Free Trial

What is Chong Kun Dang Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chong Kun Dang Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 1.58%.

Chong Kun Dang Holdings's EBITDA per Share for the three months ended in Mar. 2024 was ₩6,390.99.


Chong Kun Dang Holdings YoY EBITDA Growth Historical Data

The historical data trend for Chong Kun Dang Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Holdings YoY EBITDA Growth Chart

Chong Kun Dang Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.26 38.36 -61.54 -56.66 280.31

Chong Kun Dang Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.54 759.94 598.60 278.45 1.58

Chong Kun Dang Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chong Kun Dang Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(22510.046-5918.836)/ | 5918.836 |
=280.31 %

Chong Kun Dang Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(6390.992-6291.883)/ | 6291.883 |
=1.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chong Kun Dang Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Holdings (XKRX:001630) Business Description

Traded in Other Exchanges
N/A
Address
368, 3-ga, Choongjungro, Suhdaemoon-gu, Seoul, KOR, 120-756
Chong Kun Dang Holdings Corp manufactures and markets medicines and active pharmaceutical ingredients. It offers prescription drugs; over-the-counter pharmaceutical products; health supplements and consumer health products. Geographically activities are functioned through the region of South Korea.

Chong Kun Dang Holdings (XKRX:001630) Headlines

No Headlines